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Abstract
Introduction Eosinopenia is a cheap and forgotten marker of
acute infection that has not been evaluated previously in
intensive care units (ICUs). The aim of the present study was to
test the value of eosinopenia in the diagnosis of sepsis in
patients admitted to ICUs.
Methods A prospective study of consecutive adult patients
admitted to a 12-bed medical ICU was performed. Eosinophils
were measured at ICU admission. Two intensivists blinded to
the eosinophils classified patients as negative or with systemic
inflammatory response syndrome (SIRS), sepsis, severe sepsis,
or septic shock.
Results A total of 177 patients were enrolled. In discriminating
noninfected (negative + SIRS) and infected (sepsis + severe
sepsis + septic shock) groups, the area under the receiver
operating characteristic curve was 0.89 (95% confidence
interval (CI), 0.83 to 0.94). Eosinophils at <50 cells/mm3 yielded
a sensitivity of 80% (95% CI, 71% to 86%), a specificity of 91%
(95% CI, 79% to 96%), a positive likelihood ratio of 9.12 (95%
CI, 3.9 to 21), and a negative likelihood ratio of 0.21(95% CI,
0.15 to 0.31). In discriminating SIRS and infected groups, the
area under the receiver operating characteristic curve was 0.84
(95% CI, 0.74 to 0.94). Eosinophils at <40 cells/mm3 yielded a
sensitivity of 80% (95% CI, 71% to 86%), a specificity of 80%
(95% CI, 55% to 93%), a positive likelihood ratio of 4 (95% CI,
1.65 to 9.65), and a negative likelihood ratio of 0.25 (95% CI,
0.17 to 0.36).
Conclusion Eosinopenia is a good diagnostic marker in
distinguishing between noninfection and infection, but is a
moderate marker in discriminating between SIRS and infection
in newly admitted critically ill patients. Eosinopenia may become
a helpful clinical tool in ICU practices.
Introduction
Sepsis is one of the most common causes of morbidity and
mortality in the intensive care unit (ICU) [1]. Sepsis is generally
characterized by clinical and laboratory parameters that are
not specific and can mislead because these parameters often
change in critically ill patients with systemic inflammatory
response syndrome (SIRS) [2].
Sepsis and noninfectious SIRS produce very similar clinical
features. It is very important that clinicians have the tools to
recognize and diagnose sepsis promptly because early diag-
nosis and treatment may lead to improvement in both mortality
and morbidity [3]. An early diagnosis of sepsis before receiv-
ing the results of microbial culture would certainly facilitate the
choice of antibiotic therapy and reduce the patient mortality.
Unfortunately, the availability of a highly specific sensitive
marker of infection is still not satisfied [4]. An ideal marker of
infection would be highly specific, highly sensitive, easy to
measure, rapid, inexpensive, and correlated with the severity
and prognosis of infection. Recent studies have suggested an
important role of procalcitonin plasma concentration monitor-
ing [3-12], and more recently the triggering receptor
expressed on myeloid cells 1 [13], in the clinical diagnosis of
sepsis, because they differentiate sepsis from noninfection
CI = confidence interval; CRP = C-reactive protein; ICU = intensive care unit; IL = interleukin; PCR = polymerase chain reaction; SIRS = systemic 
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causes of SIRS. The use of procalcitonin in developing coun-
tries such as Morocco, however, remains very expensive and
hardly accessible in ICUs.
It is already known that eosinopenia typically accompanies the
response to acute infection [14]. This marked reduction in the
number of circulating eosinophil leucocytes in acute infection
was first described by Zappert in 1893 [15], and was utilized
during the first quarter of the last century as a useful diagnostic
sign [16]. After the observation that eosinopenia is part of the
normal response to stress [17], it was assumed that eosinope-
nia of acute infection is a secondary response to stress
caused by the infection [18].
The value of this old marker of acute infection was tested by
Gil and colleagues [19]. To our knowledge, however, there is
no earlier study testing the value of eosinopenia in the diagno-
sis of sepsis in the ICU. This is the first report of the reproduc-
tion of eosinopenia in acute infection on ICU admission.
The aim of the present study was to assess the value of eosi-
nopenia in differentiating sepsis-related conditions (sepsis,
severe sepsis, septic shock) from other noninfection causes of
SIRS in Moroccan critically ill patients on ICU admission.
Materials and methods
Study design and setting
A prospective study was performed of all patients consecu-
tively admitted to a 12-bed medical ICU of Rabat University
Hospital between February and May 2006. Patients who died
or were discharged within 24 hours after admission were
excluded from the study. Rabat University Hospital is the refer-
ral venue for habitants in Western-North Morocco. The 12-bed
medical ICU admits approximately 550 patients annually with
an average age of 40 years. Surgery patients, coronary
patients, neonates and burn patients are treated in specialized
units. The study protocol was approved by the hospital ethics
committee. Informed consent was not demanded because this
observational study did not require any deviation from routine
medical practice.
Data collection and definitions
At the time of ICU admission, for each patient we evaluated
their age, gender, principal diagnosis, and vital signs (body
temperature, heart rate, respiratory rate, systolic and diastolic
arterial pressure, and urine rate). The Mc Cabe index [20], the
Acute Physiology and Chronic Health Evaluation II score [21]
and the Sequential Organ Failure Assessment score [22]
were also recorded on admission. The white blood cell count,
the eosinophil cell count and the C-reactive protein (CRP)
level were only systematically recorded on admission to the
ICU and not daily during the entire ICU stay.
Blood samples were obtained by venipuncture on admission,
and subsequently each morning at 07:00 hours. The clinical
practice in the unit follows the recommendations of the task
force of the American College of Critical Care Medicine of the
Society of Critical Care Medicine [23]: blood cultures were
taken if a patient's body temperature exceeded 38.3°C, if a
patient had clinical signs of severe sepsis, or if there was a
need for vasopressor therapy for suspected septic shock. The
samples for blood cultures were taken from two different sites,
most commonly through intravascular devices (arterial can-
nula, central vein catheter or pulmonary arterial catheter.
Other cultures including urine, cerebrospinal fluid, and respi-
ratory secretions were obtained according to the clinical cir-
cumstance and before antibiotics were given. Empirical
antibiotic treatment was based on the presumptive diagnosis
and received on the day of bacteriological cultures. When bac-
teriological results became available, the antibiotics were
changed according to the pathogen isolated and the antimi-
crobial susceptibility test results.
According to the Criteria of the American College of Chest
Physicians/Society of Critical Care Medicine [2], patients
were classified as having SIRS, sepsis, severe sepsis, or sep-
tic shock at the time of admission. SIRS is defined by two or
more of the following criteria: body temperature >38°C or
<36°C, heart rate >90 beats/min, respiratory rate >20/min or
PaCO2 < 32 Torr, and white blood cell count >12,000 cells/
mm3, <4,000 cells/mm3, or >10% immature forms. Sepsis is
a SIRS associated with the presence of an infectious process.
Severe sepsis is a sepsis associated with organ dysfunction,
hypoperfusion, or hypotension (systolic blood pressure <90
mmHg or a reduction ≥ 40 mmHg from baseline). Septic
shock is a subset of severe sepsis and is defined as a persist-
ing sepsis-induced hypotension despite adequate fluid
resuscitation.
Infection was diagnosed by textbook standard criteria [24] and
was categorized according to the following: culture\micros-
copy of a pathogen from a clinical focus; positive urine dip test
in the presence of dysuria symptoms; clinical lower respiratory
tract symptoms and radiographic pulmonary abnormalities that
are at least segmental and not due to pre-existing or other
known causes; infection documented with another imaging
technique; lumbar puncture when meningitis was suspected;
obvious clinical infection (erysipelas); and identification of a
pathogen by serology or by PCR.
Importantly, two investigators retrospectively reviewed all
medical records pertaining to each patient and independently
classified the diagnosis as SIRS, sepsis, severe sepsis, or
septic shock at the time of admission on the basis of the
review of the complete patient charts, results of microbiologic
cultures, and radiographs. Both intensivists were blinded to
the eosinophil cell count and CRP levels. Concordance
among the two independent investigators was excellent and
the reliability was high (κ = 0.94).Available online http://ccforum.com/content/12/2/R59
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We assessed the value of eosinopenia as marker of sepsis by
comparing the eosinophil cell count between noninfected
patients (negative, SIRS) and infected patients (sepsis, severe
sepsis, and septic shock), and between SIRS patients and
infected patients on the day of admission to the ICU.
Laboratory measurement
Blood samples were collected in microtubes containing ethyl-
enediamine tetraacetic acid anticoagulant. The white blood
cell count and the eosinophil cell count were performed by the
Coulter (Gen·S) hematology analyzer (Beckman Coulter, Full-
erton, CA, USA). To determine the CRP level, blood samples
were drawn into green-top vacutainer tubes containing lithium-
heparin as anticoagulant. Plasma CRP was also measured by
immunoturbidimetry using the analyzer Cobas Integra (Roche
Diagnostics, Mannheim, Germany). The limits of detection
were 0.071 mg/dl.
Statistical analyses
Data are presented as the mean ± standard deviation for vari-
ables with a normal distribution, and as the median and inter-
quartile range for variables with skewed distributions.
Parametric or nonparametric tests were used for continuous
variables as appropriate after the normality of the distribution
was tested by the Kolmogorov-Smirnov test with Lilliefors cor-
rection. Statistical differences between groups were evalu-
ated by the chi-square test for categorical variables.
Comparison of group differences for continuous variables was
carried out by one-way analysis of variance or the Kruskal-Wal-
lis test. Bonferroni's post hoc test was used to locate the sig-
nificance. The Spearman rank correlation coefficient (r) was
calculated to describe the quantitative relationships between
the eosinophil count and clinical or biological features.
The best cutoff value was chosen using Younden's index.
Receiver operating characteristic curves and the respective
areas under the curves were calculated for eosinophils and
CRP. The sensitivity, specificity, and positive and negative like-
lihood ratios (with 95% confidence intervals (CIs)) were calcu-
lated at the best cutoff value. A multiple logistic regression
was performed to explore the association between the eosi-
nophil cell count, CRP levels, and infection, controlling for the
potential confounders (age, Acute Physiology and Chronic
Health Evaluation II score, Mc Cabe index, and Sequential
Organ Failure Assessment score). Results are presented as
the odds ratio and 95% CI.
A two-tailed P value <0.05 was considered significant. Statis-
tical analyses were carried out using SPSS for Windows, ver-
sion 13.0 (SPSS, Inc., Chicago, IL, USA).
Results
Characteristics of the study sample
During the study period, 198 patients were admitted to the
ICU (Figure 1), and 21 patients were excluded because of
death (n = 12) or discharge within 24 hours (n = 9). The
remaining 177 patients were enrolled into the study, having a
mean age of 42 ± 19 years. Mortality during the ICU stay
occurred in 58 out of 177 patients (33%). At the time of
admission, 120/177 patients (68%) had an infection. The
sites of infections and clinical characteristics of the study
patients are presented in Table 1.
Figure 1
Patients included and excluded from the study Patients included and excluded from the study. ICU, intensive care unit; SIRS, systemic inflammatory response syndrome.Critical Care    Vol 12 No 2    Abidi et al.
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Patients were classified as follows (Figure 1): negative group,
21% (n = 37); SIRS group, 11% (n = 20); sepsis group, 23%
(n = 41); severe sepsis group, 31% (n = 55); and septic shock
group, 14% (n = 24). Diagnoses in the negative group were
acute poisoning (n = 30), scorpion envenomation (n = 3),
acute ischemic stroke (n = 2), and hypercalcemia (n = 2).
SIRS was caused by acute exacerbation of chronic obstruc-
tive pulmonary disease (n = 6), acute asthma (n = 4), diabetic
ketoacidosis (n = 4), acute poisoning (n = 3), cardiogenic
shock (n = 2), and gastrointestinal hemorrhage (n = 1).
Infections were microbiologically documented in 70 of 120
patients (58.3%); 60% had Gram-positive infection and 40%
had Gram-negative infection. The major sources of infection
were the respiratory tract (60%) and the urinary tract (21%).
Diagnostic accuracy
The comparison of the eosinophil cell count and CRP levels
among the different groups showed significant differences
(Kruskal-Wallis test, P < 0.001) (Figure 2). There were no dif-
ferences in the leucocyte count between the different groups
(one-way analysis of variance, P = 0.095).
Concerning the comparison between the noninfected and
infected groups, the median (interquartile range) eosinophil
count was 109 (102 to 121) in noninfected patients and was
13 (8 to 28) in infected patients (P < 0.001). The median
(interquartile range) CRP was 42 (18 to 79) and 108 (58 to
198) in the noninfected and infected groups, respectively (P <
0.001). Eosinophils had a higher discriminative value than the
CRP level, with an area under the receiver operating charac-
teristic curve of 0.89 (95% CI, 0.83 to 0.94) versus 0.77 (95%
CI, 0.70 to 0.84) for CRP (P = 0.010) (Figure 3). At a cutoff
value of 50 cells/mm3, eosinophils yielded a sensitivity of 80%
(95% CI, 71% to 86%), a specificity of 91% (95% CI, 79% to
96%), a positive likelihood ratio of 9.12 (95% CI, 3.9 to 21),
and a negative likelihood ratio of 0.21 (95% CI, 0.15 to 0.31)
(Table 2). In multivariate logistic regression, the eosinophil cell
count (adjusted odds ratio per 10-cell decrease, 1.09; 95%
CI, 1.04 to 1.16; P = 0.002; frequency of significance in 1,000
bootstrap samples, 100%) and the CRP level (adjusted odds
ratio per 1-point increase, 1.01; 95% CI, 1.00 to 1.01; P=
0.019; frequency of significance in 1,000 bootstrap samples,
98%) were found to be independent predictors of infection.
Table 1
Clinical characteristics of study patients, C-reactive protein value, eosinophil count and leucocyte count in the diagnostic classes of 
patients on admission to the intensive care unit
Parameter Total (n = 177) Negative group (n = 37) SIRS (n = 20) Infected group (n = 120) P value*
Age (years) 42 ± 19 38 ± 20 35 ± 18 44 ± 18 0.077
Male gender (n (%)) 101 (57) 19 (51) 12 (60) 70 (58) 0.726
Mc Cabe index (n (%)) 0.578
Nonfatal disease 138 (78) 31 (84) 16 (80) 91 (76)
Ultimately and rapidly fatal disease 39 (22) 6 (16) 4 (20) 29 (24)
Acute Physiology and Chronic Health 
Evaluation II score
12 ± 7 7 ± 5 9 ± 5 13 ± 6 <0.001
Sequential Organ Failure Assessment 
score
3 (1 to 8) 0 (0 to 2) 1 (0 to 4) 3 (1 to 6) 0.002
ICU length of stay (days) 5 (3 to 10) 3 (2 to 5) 6 (2 to 10) 7 (4 to 11) 0.001
Sites of infection (n (%))
Respiratory tract 72 (60)
Urinary tract 25 (21)
Meningitis 16 (13)
Other 7 (6)
ICU mortality (n (%)) 58 (33) 3 (8) 5 (25) 50 (42) <0.001
Leucocyte count (cells/mm3) 13,666 ± 7,497 11,305 ± 5,136 14,595 ± 6,399 14,169 ± 8,113 0.128
Eosinophil count (cells/mm3) 13 (0 to 83) 146 (54 to 250) 22 (13 to 85) 8 (0 to 36) <0.001
C-reactive protein (mg/l) 84 (31 to 155) 19 (36 to 79) 59 (16 to 84) 108 (58 to 197) <0.001
Data are expressed as median (interquartile range) or as mean ± standard deviation. *P values are from the chi-squared test, one-way analysis of 
variance, or the Kruskal-Wallis test to compare the differences between the three groups. ICU, intensive care unit; SIRS, systemic inflammatory 
response syndrome group.Available online http://ccforum.com/content/12/2/R59
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Concerning the comparisons between the SIRS and the
infected groups (Figure 4), the median (interquartile range)
eosinophil cell count was 121 (64 to 121) in SIRS patients
and was 13 (8 to 28) in infected patients (P < 0.001). The
median (interquartile range) CRP level was 59 (17 to 85) and
108 (58 to 198) in the SIRS and infected groups, respectively
(P < 0.001). The area under the receiver operating character-
istic curve was 0.84 (95% CI, 0.74 to 0.94) for eosinophils
versus 0.77 (95% CI, 0.67 to 0.87) for CRP (Figure 5). The
comparison of the areas under the receiver operating charac-
teristic curves between eosinophils and CRP was not signifi-
cant (P  = 0.175). At a cutoff value of 40 cells/mm3,
eosinophils yielded a sensitivity of 80% (95% CI, 71% to
86%), a specificity of 80% (95% CI, 55% to 93%), a positive
likelihood ratio of 4 (95% CI, 1.65 to 9.65), and a negative like-
lihood ratio of 0.25 (95% CI, 0.17 to 0.36) (Table 2). In multi-
variate logistic regression, only the eosinophil cell count
(adjusted odds ratio per 10-cell decrease, 1.07; 95% CI, 1.01
to 1.14; P = 0.019; frequency of significance in 1,000 boot-
strap samples, 90%) was found to be an independent predic-
tor of infection.
Figure 2
Eosinophil cell count and C-reactive protein level in the different diagnostic groups Eosinophil cell count and C-reactive protein level in the different diagnostic groups. Box plot of eosinophil cell count and C-reactive protein (CRP) 
level in the different diagnostic groups. SIRS, systemic inflammatory response syndrome. Central line, median; boxes, 25th to 75th percentiles; 
whiskers, 95% confidence intervals.Critical Care    Vol 12 No 2    Abidi et al.
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Correlations
There were correlations between the eosinophil cell count and
CRP level (r = -0.312, P < 0.001), between the eosinophil cell
count and systolic blood pressure (r = 0.162, P = 0.030),
between the eosinophil cell count and respiratory rate (r = -
0.195, P = 0.011), between the eosinophil cell count and
heart rate (r = -0.335, P < 0.001), and between the eosinophil
cell count and Acute Physiology and Chronic Health Evalua-
tion II score (r = -0.265, P < 0.001). No correlation was found
between eosinophils and leucocytes or other clinical or biolog-
ical features.
Discussion
The present study is the first to suggest the value of eosinope-
nia in differentiating sepsis-related conditions from other
inflammatory causes of SIRS in the ICU. Our results show the
higher sensitivity and specificity of eosinopenia compared with
the CRP level in the diagnosis of sepsis on admission to the
ICU. Eosinopenia can therefore represent a good marker for
the diagnosis of sepsis on ICU admission.
The diagnosis of sepsis is difficult, particularly in the ICU
where signs of sepsis may be present in absence of a real
infection [25]. The effort of many investigating groups has
been to find a reliable marker to discriminate the inflammatory
response to infection from other types of inflammation. Gold
standards for the diagnosis of infection do not exist [3]; but
procalcitonin is known to be among the most promising sepsis
markers in critically ill patients, and is capable of complement-
ing clinical signs and routine laboratory variables that are sug-
gestive of sepsis [3-12]. The procalcitonin plasma
concentration measure remains expensive in countries with
low income and is not systematically used in our hospital. Our
results, however, did show the interest of the cheap, old and
forgotten sepsis marker that is eosinopenia, because it can
perform as well as procalcitonin in the diagnosis of sepsis on
ICU admission. Moreover, the effectiveness of this sepsis
marker in our study was assessed in the differential diagnosis
between all sepsis-related conditions and SIRS.
The mortality rate in our study seems high (33%) and is essen-
tially related to infection. This observation can be explained as
follows. First, infection is a common cause of admission to our
medical ICU [26,27], which may be due to the lack of a spe-
cific unit for infectious diseases in our hospital, limited
healthcare resources in the Moroccan context, delayed pres-
entation of severely sick patients to the ICU, or a high preva-
lence of hospital-acquired infection in our hospital [28].
Second, our results show that mortality among the infected
group was 42%; this rate appears to be high but is compara-
ble with other studies [29,30] where reported ICU mortality
related to sepsis conditions vary between 28% and 54%.
Eosinopenia was a sepsis marker in our study. The study by Gil
and colleagues in a department of internal medicine showed
that an inflammatory syndrome associated with an eosinophil
count <40 cells/mm3 is related to bacterial infectious diseases
[19]. In an experimental study, Bass and colleagues produced
eosinopenia in rabbits and in humans using chimiotactic fac-
tors of acute inflammation [14]. In trauma patients, however,
Dipiro and colleagues found an increased eosinophil count
after sepsis [31]. This eosinophil production was enhanced by
IL-4 and IL-5, and suggests a T-helper lymphocyte type 2
cytokine activation in response to sepsis after traumatic injury.
Eosinophils normally account for only 1% to 3% of peripheral
blood leucocytes, and the upper limit of the normal range is
350 cells/mm3 blood [32]. The level of eosinophils in the body
is normally tightly regulated. Mechanisms that control eosi-
nopenia in acute infection, also considered as an acute stress,
involve mediation by adrenal glucocorticosteroids and epine-
phrine [14]. Also, the initial eosinopenic response to acute
infections was interpreted as being the result of a rapid periph-
eral sequestration of circulating eosinophils. Part of the
sequestration could be ascribed to migration of eosinophils
into the inflammatory site itself, presumably by chemotactic
substances released during acute inflammation. The major
chemotactic substances include C5a and fibrin fragments that
Figure 3
Eosinophil cell count and C-reactive protein level for discrimination of  noninfection and infection Eosinophil cell count and C-reactive protein level for discrimination of 
noninfection and infection. Receiver operating characteristic (ROC) 
curve of eosinophil cell count and C-reactive protein (CRP) level for the 
discrimination of noninfected patients (negative + systemic inflamma-
tory response syndrome) and infected patients (sepsis + severe sepsis 
+ septic shock). Areas under the ROC curves were 0.89 (95% confi-
dence interval, 0.83 to 0.94) for eosinophils and 0.77 (95% confidence 
interval, 0.70 to 0.84) for CRP. Comparison of the areas under ROC 
curves between eosinophils and CRP, P = 0.010.Available online http://ccforum.com/content/12/2/R59
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have been detected in the circulation during acute inflamma-
tory states [14].
If the hypothetical mechanism of eosinopenia as the migration
of eosinophils to the inflammatory site is taken into account,
this may explain the difference found between sepsis-related
conditions and SIRS in our study. The lack of differences
between sepsis, severe sepsis and septic shock groups, how-
ever, may be explained by the low rate of eosinophil count
(near zero) in the infection groups. This suggests a floor effect
of eosinopenia in infection groups.
The optimal eosinophil cutoff values have not yet been estab-
lished and may differ depending on the clinical setting and the
site and the etiology of infection. Furthermore, the diagnostic
performance of eosinophils in our study is comparable with
procalcitonin in patients with suspected sepsis in a study
reported by Gibot and colleagues (sensitivity, 84%; specifi-
city, 70%) [13]. In a meta-analysis the diagnostic performance
of procalcitonin was low, with the mean value of both sensitiv-
ity and specificity being 71% (95% CI, 67 to 76) [33].
In the present study, eosinophils showed weak but significant
correlations with sepsis parameters – and with the severity of
the disease. In addition, eosinophils correlate to CRP, which is
a proinflammatory marker. These correlations, although weak,
seem to confirm the proinflammatory role of eosinophils in
human sepsis. Gaïni and colleagues have also found weak
correlation between the biological marker of infection high-
mobility group-box 1 protein and proinflammatory markers
[34]. Gibot and colleagues did not find any correlation
between triggering receptor expressed on myeloid cells 1 and
CRP, procalcitonin or any clinical and biological features [13].
The present study has a potentially important implication for
clinicians in developing countries. As a cheap test to diagnose
sepsis on ICU admission, eosinopenia offers a higher degree
of certainty than other currently available tests or markers.
Eosinopenia might guide physicians in their clinical decisions
and may provide a stepwise approach to the complex manage-
ment of critically ill patients.
The present study has several strengths. The study sample
was large and involved a diverse group of critically ill adults
admitted to a medical ICU. Blinded investigators determined
each patient's diagnosis without knowledge of the eosinophil
cell count and CRP levels. Finally, our study was designed as
a real-life study. Some limitations of the study do, however,
merit consideration. The eosinophil count and the CRP value
were collected only on the day of ICU admission and not daily
during the entire ICU stay. This cannot allow us to generalize
our findings to evaluate the prognostic value of eosinopenia.
As we used clinical criteria and microbiological evidence, it
may have been difficult to ascertain the exact cause of SIRS in
all patients. No surgical patients were enrolled because of the
specificity of our medical ICU. Finally, infections were micro-
biologically documented in 58% of cases; this low percentage
may be explained by the frequency of respiratory tract infection
in our study (60% of cases), because microorganisms are not
usually isolated in respiratory tract infections [35,36].
Conclusion
Eosinopenia can be used as a diagnostic marker of sepsis in
newly admitted critically ill patients. Eosinopenia is a better
diagnostic marker than CRP, and may become a helpful clini-
cal tool in ICU practices. Further studies are needed to evalu-
ate the progression of eosinopenia with the severity of sepsis
and to establish the best cutoff values for this marker.
Competing interests
The authors declare that they have no competing interests.
Table 2
Diagnostic performance of the eosinophil count and the C-reactive protein level in the prediction of sepsis on intensive care unit 
admission
Variable Noninfection versus infection SIRS versus infection
C-reactive protein level Eosinophil cell count C-reactive protein level Eosinophil cell count
Cutoff value >70 mg/l <50 cells/mm3 >80 mg/l <40 cells/mm3
Sensitivity (%) 68 (59 to 76) 80 (71 to 86) 68 (59 to 79) 80 (71 to 86)
Specificity (%) 61 (47 to 74) 91 (79 to 96) 55 (32 to 76) 80 (55 to 93)
Positive likelihood ratio 1.77 (1.25 to 2.51) 9.12 (3.9 to 21) 1.52 (0.92 to 2.50) 4.00 (1.65 to 9.65)
Negative likelihood ratio 0.52 (0.39 to 0.69) 0.21 (0.15 to 0.31) 0.57 (0.41 to 0.81) 0.25 (0.17 to 0.36)
Area under the receiver operating characteristic 
curve
0.77 (0.70 to 0.84) 0.89 (0.83 to 0.94) 0.77 (0.67 to 0.87) 0.84 (0.74 to 0.94)
Data in parentheses are 95% confidence intervals. Noninfection, negative + systemic inflammatory response syndrome (SIRS); infection, sepsis + 
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